Anzeige
Mehr »
Lynx Broker
Login
Samstag, 19.10.2019 Börsentäglich über 12.000 News von 614 internationalen Medien
Magisch! Weg frei für die >Milliarden-Chance< im Pennystockmantel!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 896047 ISIN: US09058V1035 Ticker-Symbol: BO1 
Tradegate
18.10.19
17:09 Uhr
2,160 Euro
-0,080
-3,57 %
1-Jahres-Chart
BIOCRYST PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
BIOCRYST PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
2,140
2,160
18.10.
2,140
2,160
18.10.

Aktuelle News zur BIOCRYST PHARMACEUTICALS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
07.10.BioCryst: Much At Stake In Next Phase I Results Of BCX99308
Börsennews zur BIOCRYST PHARMACEUTICALS Aktie und weiteren Hot Stocks erhalten
26.09.BioCryst Pharmaceuticals: Waiting For A Cash Infusion7
24.09.BioCryst Pharmaceuticals, Inc.: BioCryst Pharmaceuticals to Present at Cantor Global Healthcare Conference1
23.09.Here's Why BioCryst Pharmaceuticals Popped Today9
23.09.BIOCRYST PHARMACEUTICALS INC - 8-K, Current Report-
16.09.BioCryst up 4% on extended timeline for debt financing1
16.09.BIOCRYST PHARMACEUTICALS INC - 8-K, Current Report-
10.09.After BioCryst fizzle, a new oral HAE player emerges4
09.09.BioCryst Pharmaceuticals Inc. Represents Good Entry Opportunity At Current Prices2
03.09.BioCryst Pharmaceuticals, Inc.: BioCryst to Present at H.C. Wainwright Global Investment Conference-
08.08.BIOCRYST PHARMACEUTICALS INC - 10-Q, Quaterly Report-
06.08.BioCryst Pharmaceuticals, Inc. (BCRX) CEO Jon Stonehouse on Q2 2019 Results - Earnings Call Transcript3
06.08.BIOCRYST PHARMACEUTICALS INC - 8-K, Current Report2
05.08.BioCryst Pharmaceuticals, Inc.: BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)-
23.07.BioCryst Pharmaceuticals, Inc.: BioCryst to Report Second Quarter 2019 Financial Results on August 6-
03.07.BioCryst Pharmaceuticals, Inc.: BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)1
01.07.BioCryst Pharmaceuticals, Inc.: BioCryst Appoints Megan Sniecinski Chief Business Officer2
27.06.BIOCRYST PHARMACEUTICALS INC - 8-K, Current Report-
20.06.BioCryst Pharmaceuticals (BCRX) Presents At JMP Securities Life Sciences Conference - Slideshow2
07.06.BioCryst Pharmaceuticals (BCRX) Presents At Jefferies 2019 Healthcare Conference - Slideshow5
Seite:  Weiter >>
47 Nachrichten in den letzten 12 Monaten

Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1